Novo Nordisk CEO talks GLP-1 pill at JPMorgan conference

A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…

Abivax Stock Rises to Become Top Biotech Acquisition Target

Europe's best-performing blue-chip stocks in 2025 are expected to be bought by a larger peer, in a deal analysts say…